Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity New England Journal of Medicine EASD 2023: meta analysis shows tirzepatide superiority to semaglutide Clinical Trials Arena For an adult with type 2 diabetes mellitus who requires substantial weight loss, what are the recommended use, dosing, regulatory approval status, and contraindications of tirzepatide compared with cagrilintide, and what alternative Cagrilintide, an amylin analogue, is a promising medication for weight loss by enhancing satiety, delaying gastric emptying, and suppressing appetite. In my patients, I have also seen increased